Bio-Techne (TECH) Q2 2024 Annual Earnings
TECH·Reported August 7, 2024·Before market open·FQ4 FY2024
Bio-Techne reported Q2 2024 revenue of $306.1M, missed analyst consensus of $306.5M by $387.9K. Diluted EPS came in at $0.49, missed the $0.49 consensus by $0.00.
Revenue
$306.1Mmissed by $387.9K
Consensus: $306.5MDiluted EPS
$0.49missed by $0.00
Consensus: $0.49
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Bio-Techne's Q2 2024 earnings report.
Bio-Techne (TECH) reported Q2 2024 earnings on August 7, 2024 before market open.
Bio-Techne reported revenue of $306.1M and diluted EPS of $0.49 for Q2 2024.
Revenue missed the consensus estimate of $306.5M by $387.9K. EPS missed the consensus estimate of $0.49 by $0.00.
You can read the 10-K periodic report (0001558370-24-012430) directly on SEC EDGAR. The filing index links above go to sec.gov.